Navigation Links
Niaid / Barda Awards Elusys a $12 Million Contract to Further Develop Anthim, the Company's Anthrax Therapeutic
Date:9/25/2007

PINE BROOK, N.J., Sept. 25 /PRNewswire/ -- Elusys Therapeutics, Inc. (Elusys), a privately held biopharmaceutical company developing antibody-based therapies for the treatment of life-threatening infectious diseases, today announced it has been awarded a contract for $12 million for advanced development of Anthim(TM), the company's late-stage anthrax therapeutic. This project has been funded in whole or in part with Federal funds from the National Institute of Allergy and Infectious Disease, National Institutes of Health and the Biomedical Advanced Research and Development Authority, Department of Health and Human Services, under Contract No. HHSN272200700035C. To date, Elusys has received more than $32 million from NIAID/BARDA and the Department of Defense in support of Anthim and the company's Heteropolymer Antibody(TM) technology.

Elizabeth Posillico, Ph.D., President and Chief Executive Officer of Elusys, commented on the award, "Elusys is encouraged by the continued support from the U.S. Government and we look forward to extending our collaboration with NIAID/BARDA. We are confident that Elusys has developed a highly effective and valuable anthrax therapeutic for procurement under Project BioShield for addition to the U.S. Government's Strategic National Stockpile."

Dr. Posillico continued, "Inhalation of anthrax spores rapidly leads to death if patients are not treated immediately with specific antibiotics. Typically, victims of inhalation anthrax experience only vague symptoms until it is too late, when they are in toxemia, leaving antibiotics largely ineffective. Anthrax vaccines are also ineffective unless victims are immunized well in advance of exposure. Anthim represents a 'just in time anthrax therapeutic,' that in relevant models has demonstrated complete protection against an anthrax spore challenge with a single prophylactic dose, and has shown significant protection when administered up to two days after a lethal spore challenge,
'/>"/>

SOURCE Elusys Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Pelosi: Bush Veto of Stem Cell Bill Says No to the Hopes of Million of Families Across America
2. Trichomoniasis: Most Common Curable STD in U.S. Affects 7.4 Million Annually
3. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
4. Molecular Target of Bradmers Neuradiab Further Validated by Independent Findings
5. Phase III Clinical Trial with 4-Month Long-Acting Formulation of Triptorelin: Ipsen Decides Not to Perform Further Administration
6. Further Statistical Analysis of the Recent Phase III trial on Lead Product M6G Shows Additional Benefits
7. New Data on Market-Leading Velcade (Bortezomib) for Injection Further Strengthen Role in Previously Treated Multiple Myeloma
8. Liponex Inc. Reports Further Analysis of CRD5 Phase I/II Clinical Trial Data
9. MIV Therapeutics Announces Pivotal Test Results Further Validating Company Stent Coatings Meet Critical FDA Fatigue Guidelines
10. Lexicon Develops Antibodies That Lower Triglycerides and Cholesterol as Potential New Therapy for Heart Disease
11. Positive Clinical Results for DG041 Lead Product Development Highlights at deCODE R&D Event
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014  In part ... to leverage a hospital pharmacy as a strategic asset, ... national practice leader for Cardinal Health,s Innovation Delivery Solutions ... care can benefit both hospitals and patients. ... only one part of their job in a value-based ...
(Date:8/29/2014)... , Aug. 29, 2014 Research and ... Orthopedic Soft Tissue Repair Devices Market 2014-2018" report ... are the mass of cells that connect, support, or ... tissues such as tendons, ligaments, cartilage, fascia, and other ... of these tissues with age result in wear and ...
(Date:8/28/2014)... NEW YORK , Aug. 28, ... a new market research report is ... Testing Laboratories, Safety and Compliance Services ... Metrics and Revenue Forecasts to 2021, ... http://www.reportlinker.com/p02347353/Testing-Laboratories-Safety-and-Compliance-Services-Industry-US--Analytics-Extensive-Financial-Benchmarks-Metrics-and-Revenue-Forecasts-to-2021-NAIC-541380 .html Testing ...
Breaking Medicine Technology:Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 2Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 3Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 4Global Orthopedic Soft Tissue Repair Devices Market 2014-2018: Key Vendors are ArthroCare, Biomet, DePuy Synthes and Smith & Nephew 2Global Orthopedic Soft Tissue Repair Devices Market 2014-2018: Key Vendors are ArthroCare, Biomet, DePuy Synthes and Smith & Nephew 3Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 2Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 3Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 4Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 5Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 6
... Hedgeye Risk Management Healthcare team, led by Tom Tobin, will host ... Demographics of Demand and Profits in Healthcare," where we will be ... 1994-2002 was so good, and why the next decade looks so ... for hip, knee, and spine device growth. -   ...
... Oct. 6 Pharmaceutical and biotech companies reach much ... partnerships between R&D and marketing, balancing therapeutic innovation with ... requires companies to break down the walls that have ... strengths of both talented medical researchers and skillful marketers. ...
Cached Medicine Technology:Aging of America: Demographics of Demand and Profits in Healthcare 2Creating Partnerships Across R&D and Marketing to Ensure a Successful Global Launch 2
(Date:8/29/2014)... August 29, 2014 Senior Independence ... operations & business development. , Rees has been with ... of business development. , A wholly owned subsidiary of ... provides older adults with options, including personalized home health ... (e.g., meal preparation) and therapeutic adult day centers. , ...
(Date:8/29/2014)... 29, 2014 Los Angeles dental ... mini implants to area patients. With this treatment, patients ... long-term teeth shifting and loss of appearance. Although mini ... implants , their smaller size allows for less ... easier recovery. Once placed, mini implants can be topped ...
(Date:8/29/2014)... A home should be a safe haven, but there ... Amica Insurance is sharing some tips to help improve safety in ... following safety measures: , Kitchen, , Store hazardous ... and keep them away from food. , ... , Bathroom , Put slip-resistant ...
(Date:8/29/2014)... life support (BLS) videos available on YouTube provide ... according to a new study published in ... Australasian College for Emergency Medicine (ACEM). , ... are known to improve survival for,victims. , A ... the study, which reviewed educational videos from the ...
(Date:8/29/2014)... Saturday 30 August 2014: New ESC registries ... coronary syndromes (ACS). The announcement comes as the ... and the study on heart failure patients conducted ... and Development (OECD) begins an outcomes evaluation. , ... EURObservational Research Programme (EORP). , Professor Roberto Ferrari, ...
Breaking Medicine News(10 mins):Health News:Senior Independence Promotes Rees to Vice President of Operations & Business Development 2Health News:Dental Implants Dentist, Kevin Sands DDS, Is Now Offering Mini Implants 2Health News:Improve Home Safety with Tips from Amica Insurance 2Health News:New ESC registries launched on cardiac oncology and ACS 2Health News:New ESC registries launched on cardiac oncology and ACS 3Health News:New ESC registries launched on cardiac oncology and ACS 4
... ... of software & technology to Home Medical Equipment, Durable Medical Equipment, Respiratory ... a solution for each individual segment of Home Care as well as ... provider offering several or all of these product/service lines within one integrated ...
... ... interactive database on tap water quality. The data has been compiled from state environment ... concerning the database. , ... Washington (Vocus) December 11, 2009 -- On December 12, 2009, the Environmental Working ...
... 11 They feature real patients, real stories and ... campaign titled "Real Patients, Real Stories" won Platinum in ... event held in Chicago this fall. , Baylor teamed ... the non-traditional spots. The documentary-style ads feature actual patients ...
... sensory problems before onset of complex disease symptoms benefits ... -- Identifying sight and hearing problems in teens who ... doctors fully restore those senses and lessen the impact ... A new study found that problems in basic sensory ...
... A gene commonly studied by cancer researchers has been linked ... Understanding how the gene works means scientists may be ... a study by Texas AgriLife Research appearing in the Journal ... understand the mechanism, or how the gene works, we believe a ...
... The Visiting Nurse Association (VNA) of Greater Philadelphia is ... who reside in lower Bucks County. , The ... wound and ostomy care, and chronic care services. Nurses, ... to patients in their homes. , VNA also ...
Cached Medicine News:Health News:Fastrack Announces Enhancements to the Enterprise System for Home Care 2Health News:Statement from American Water Works Association on the Environmental Working Group's report on Tap Water Quality Testing and Violations 2Health News:Baylor Health Care System's Patient Testimonial Ad Campaign Wins National Award 2Health News:Early Treatment of Hearing, Vision Helps in Schizophrenia 2Health News:Study shows how gene action may lead to diabetes prevention, cure 2Health News:The Visiting Nurse Association of Greater Philadelphia Expands Service to Bucks County 2
Inquire...
Flextend is a hydrocolloid skin barrier that is designed to be the most resistant to discharge and is the barrier of choice for urostomies and high output ileosotomies....
Premier pouches provide the ultimate in skin protection with our long wearing Flextend skin barriers and superior comfort with our soft and silky ComfortWear panels....
... APTT-based kit for the screening of factor-V-related ... of the test for the factor V:Q506 ... plasma with an excess of V-DEF Plasma ... to discriminate between heterozygous and homozygous factor ...
Medicine Products: